open access

Vol 87, No 5 (2019)
ORIGINAL PAPERS
Published online: 2019-10-31
Submitted: 2019-05-07
Accepted: 2019-09-02
Get Citation

Effect of yoga on FEV1, 6-minute walk distance (6-MWD) and quality of life in patients with COPD group B

Resti Yudhawati, Mariani Rasjid Hs
DOI: 10.5603/ARM.2019.0047
·
Pubmed: 31680225
·
Adv Respir Med 2019;87(5):261-268.

open access

Vol 87, No 5 (2019)
ORIGINAL PAPERS
Published online: 2019-10-31
Submitted: 2019-05-07
Accepted: 2019-09-02

Abstract

Introduction: Yoga is used in the treatment of various diseases, including chronic obstructive pulmonary disease. However, no studies have assessed the effect of yoga on COPD patients in Indonesia. The difference between this study and similar studies completed in other countries lies in the type of yoga exercises completed, the method in which they were completed, and in certain, unique demographic characteristics. This study aims to analyze the effect of yoga on FEV1, 6-minute walk distance, and quality of life in patients with COPD group B in Indonesia.
Material and methods: This article reflects research done in the form of an experimental study using a randomized controlled trial with pre and post-test control group design. The samples were divided into 2 groups: the treatment group (yoga practice for 1 hour, 2 times a week for 12 weeks) and the control group (untreated with yoga, given lung rehabilitation brochure). Assessment of the effect of yoga exercises on lung function parameters (FEV1), 6-minute walk distance and quality of life were used using SGRQ questionnaires in COPD group B.
Results: 33 COPD patients fulfilled the inclusion criteria. 30 patients completed the study. Pre and post yoga results were evalu-ated in the treatment group versus the control group and then further assessed using statistical tests. There was a significant in-crease in FEV1, 6-MWD and quality of life using a SGRQ questionnaire after 12 weeks of yoga (p < 0.05) as well as a a significant change in FEV1, 6-MWD and quality of life in the treatment group (p < 0.05) when compared with the control group (p > 0.05). Conclusions: Yoga affects FEV1, 6-MWD, and quality of life in patients with Group B COPD.

Abstract

Introduction: Yoga is used in the treatment of various diseases, including chronic obstructive pulmonary disease. However, no studies have assessed the effect of yoga on COPD patients in Indonesia. The difference between this study and similar studies completed in other countries lies in the type of yoga exercises completed, the method in which they were completed, and in certain, unique demographic characteristics. This study aims to analyze the effect of yoga on FEV1, 6-minute walk distance, and quality of life in patients with COPD group B in Indonesia.
Material and methods: This article reflects research done in the form of an experimental study using a randomized controlled trial with pre and post-test control group design. The samples were divided into 2 groups: the treatment group (yoga practice for 1 hour, 2 times a week for 12 weeks) and the control group (untreated with yoga, given lung rehabilitation brochure). Assessment of the effect of yoga exercises on lung function parameters (FEV1), 6-minute walk distance and quality of life were used using SGRQ questionnaires in COPD group B.
Results: 33 COPD patients fulfilled the inclusion criteria. 30 patients completed the study. Pre and post yoga results were evalu-ated in the treatment group versus the control group and then further assessed using statistical tests. There was a significant in-crease in FEV1, 6-MWD and quality of life using a SGRQ questionnaire after 12 weeks of yoga (p < 0.05) as well as a a significant change in FEV1, 6-MWD and quality of life in the treatment group (p < 0.05) when compared with the control group (p > 0.05). Conclusions: Yoga affects FEV1, 6-MWD, and quality of life in patients with Group B COPD.

Get Citation

Keywords

yoga, COPD, FEV1, 6-MWD, quality of life, SGRQ

About this article
Title

Effect of yoga on FEV1, 6-minute walk distance (6-MWD) and quality of life in patients with COPD group B

Journal

Advances in Respiratory Medicine

Issue

Vol 87, No 5 (2019)

Pages

261-268

Published online

2019-10-31

DOI

10.5603/ARM.2019.0047

Pubmed

31680225

Bibliographic record

Adv Respir Med 2019;87(5):261-268.

Keywords

yoga
COPD
FEV1
6-MWD
quality of life
SGRQ

Authors

Resti Yudhawati
Mariani Rasjid Hs

References (18)
  1. World Health Organization. Chronic respiratory diseases. Burden of COPD. Available at: https://www who int/respiratory/copd/burden/en [access: 14.09.2019].
  2. Sethi S, Evans N, Grant BJB, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002; 347(7): 465–471.
  3. Global Initiative for Chronic Obstructive Lung Disease. GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available at: https://goldcopd.org. [access: 14.09.2019].
  4. Ikalius Y, Yunus F, Suradi F, et al. Changes in the quality of life and functional capacity of patients with chronic obstructive pulmonary disease after pulmonary rehabilitation. Maj Kedokt Indones. 2007; 57(12): 447.
  5. Duerden M. The management of chronic obstructive pulmonary disease. MeRec Bull. 2006; 16(5): 17–20.
  6. Chandra F. Respiratory practices in yoga. Behavioral and Psychological Approaches to Breathing Disorders. 1994: 221–232.
  7. Quanjer PH, Stanojevic S, Cole TJ, Stocks J. GLI-2012 Desktop Software for Individual Calculations. Version 3.3.1 build 5. 2014. Available at: https://www.ers-education.org/guidelines/global-lung-function-initiative/spirometry-tools/desktop-individual-calculator.aspx [access: 10.10.2019].
  8. Liu XC, Pan L, Hu Q, et al. Effects of yoga training in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Thorac Dis. 2014; 6(6): 795–802.
  9. Katiyar SK, Bihari S. Role of pranayama in rehabilitation of COPD patients -a randomized controlled study. Indian J Allergy Asthma Immunol. 2006; 20(2): 98–104.
  10. Donesky-Cuenco D, Nguyen HQ, Paul S, et al. Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. J Altern Complement Med. 2009; 15(3): 225–234.
  11. Thombre DP, Balakumar B, Nambinarayanan TK, et al. Effect of yoga training on reaction time, respiratory endurance and muscle strength. Indian J Physiol Pharmacol. 1992; 36(4): 229–233.
  12. Ranjita R, Hankey A, Nagendra HR, et al. Yoga-based pulmonary rehabilitation for the management of dyspnea in coal miners with chronic obstructive pulmonary disease: A randomized controlled trial. J Ayurveda Integr Med. 2016; 7(3): 158–166.
  13. Fulambarker A, Farooki B, Kheir F, et al. Effect of yoga in chronic obstructive pulmonary disease. Am J Ther. 2012; 19(2): 96–100.
  14. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet. 1996; 348(9035): 1115–1119.
  15. Berry MJ, Rejeski WJ, Adair NE, et al. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med. 1999; 160(4): 1248–1253.
  16. Kulpati DD, Kamath RK, Chauhan MR. The influence of physical conditioning by yogasanas and breathing exercises in patients of chronic obstructive lung disease. J Assoc Physicians India. 1982; 30(12): 865–868.
  17. Kinasih A. The influence of yoga practice on improving the quality of life. Bull Psychol. 2002; 18(1): 1–12.
  18. Villien F, Yu M, Barthélémy P, et al. Training to yoga respiration selectively increases respiratory sensation in healthy man. Respir Physiol Neurobiol. 2005; 146(1): 85–96.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl